Stephane Bancel, Chief Executive Officer at Moderna, Inc. (MRNA), sold 159,200 shares at $148.27 ($24.3M) on 2023-02-23, disclosed to the SEC on 2023-02-24.
Seasonal sale ($24.3M) by Chief Executive Officer — this insider has traded MRNA in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $157.87 | 10,472 | $1.7M | 6.8% |
| 2 | $157.87 | 10,472 | $1.7M | 6.8% |
| 3 | $158.53 | 20,303 | $3.2M | 13.3% |
| 4 | $158.53 | 20,303 | $3.2M | 13.3% |
| 5 | $159.59 | 8,725 | $1.4M | 5.7% |
| 6 | $159.59 | 8,725 |
| $1.4M |
| 5.7% |
| 7 | $160.28 | 500 | $80K | 0.3% |
| 8 | $144.45 | 7,314 | $1.1M | 4.4% |
| 9 | $144.45 | 7,314 | $1.1M | 4.4% |
| 10 | $145.25 | 7,486 | $1.1M | 4.5% |
| 11 | $145.25 | 7,486 | $1.1M | 4.5% |
| 12 | $146.75 | 12,890 | $1.9M | 7.8% |
| 13 | $146.75 | 12,890 | $1.9M | 7.8% |
| 14 | $147.43 | 8,256 | $1.2M | 5.0% |
| 15 | $147.43 | 8,256 | $1.2M | 5.0% |
| 16 | $148.27 | 3,754 | $557K | 2.3% |
| 17 | $148.27 | 3,754 | $557K | 2.3% |
| 18 | $149.86 | 300 | $45K | 0.2% |
| Total | $152.46 avg | 159,200 | $24.3M | 100% |
| Filing → |
| MRNA | SELL | 2024-02-16 | $4.7M | — | Filing → |
| MRNA | SELL | 2023-06-30 | $6.6M | — | Filing → |
| MRNA | SELL | 2023-06-23 | $19.3M | — | Filing → |